Trial Profile
Phase IIb Multicenter Randomized Comparative Study of Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for Chronic Inflammatory Bowel Disease
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 19 Jun 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms PneumoMICI
- 13 Jun 2023 Status changed to discontinued, according to ClinicalTrials.gov: US National Institutes of Health record.
- 03 Feb 2021 Planned End Date changed from 1 Dec 2021 to 1 Jul 2022.
- 24 Jan 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2021.